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Previous studies indicate that leptin secretion is regulated by
insulin-mediated glucose metabolism. Because fructose, un-
like glucose, does not stimulate insulin secretion, we hypoth-
esized that meals high in fructose would result in lower leptin
concentrations than meals containing the same amount of
glucose. Blood samples were collected every 30–60 min for
24 h from 12 normal-weight women on 2 randomized days
during which the subjects consumed three meals containing
55, 30, and 15% of total kilocalories as carbohydrate, fat, and
protein, respectively, with 30% of kilocalories as either a fruc-
tose-sweetened [high fructose (HFr)] or glucose-sweetened
[high glucose (HGl)] beverage. Meals were isocaloric in the
two treatments. Postprandial glycemic excursions were re-
duced by 66  12%, and insulin responses were 65  5% lower
(both P < 0.001) during HFr consumption. The area under the
curve for leptin during the first 12 h (33 7%; P < 0.005), the
entire 24 h (21  8%; P < 0.02), and the diurnal amplitude
(peak  nadir) (24  6%; P < 0.0025) were reduced on the HFr
day compared with the HGl day. In addition, circulating levels
of the orexigenic gastroenteric hormone, ghrelin, were sup-
pressed by approximately 30% 1–2 h after ingestion of each
HGl meal (P < 0.01), but postprandial suppression of ghrelin
was significantly less pronounced after HFr meals (P < 0.05 vs.
HGl). Consumption of HFr meals produced a rapid and pro-
longed elevation of plasma triglycerides compared with the
HGl day (P < 0.005). Because insulin and leptin, and possibly
ghrelin, function as key signals to the central nervous system
in the long-term regulation of energy balance, decreases of
circulating insulin and leptin and increased ghrelin concen-
trations, as demonstrated in this study, could lead to in-
creased caloric intake and ultimately contribute to weight
gain and obesity during chronic consumption of diets high in
fructose. (J Clin Endocrinol Metab 89: 2963–2972, 2004)
WE HAVE PREVIOUSLY reported that consumption ofhigh-fat meals, which produce smaller postprandial
glucose and insulin responses than equicaloric high-carbo-
hydrate meals, reduces 24-h circulating leptin concentrations
in humans (1). This reduction of leptin concentrations is
likely the result of decreased insulin-mediated glucose me-
tabolism in adipose tissue (2). Because insulin and leptin
function as key signals conveying information on energy
intake and body fat stores to the central nervous system
(CNS) for the long-term regulation of food intake and energy
homeostasis (3, 4), it is possible that reduced insulin and
leptin production contributes to increased energy intake,
weight gain, and obesity in animals and humans consuming
high-fat diets. In contrast, high-carbohydrate, low-fat diets
are known to induce weight loss, even when consumed ad
libitum (5, 6).
However, not all types of dietary carbohydrate are likely
to have the same effect on these signals of peripheral energy
status. Fructose, unlike glucose, does not stimulate insulin
secretion from pancreatic -cells (7). In rhesus monkeys, an
8-h iv fructose infusion resulted in markedly reduced insulin
secretion and did not increase circulating leptin concentra-
tions compared with infusion of the same amount of glucose,
which increased plasma leptin levels by more than 50%
above baseline fasting levels (8). Thus, similar to fat, fructose
does not increase insulin-mediated glucose metabolism or
circulating leptin levels. Even a relative deficit in leptin pro-
duction has been shown to be associated with increased body
adiposity in humans (9). In addition, it has recently been
reported that an augmentation of the proportional amplitude
(nadir to peak) of the 24-h diurnal pattern of circulating
leptin concentrations was predictive of the extent of weight
and body fat loss during a 12-wk ad libitum low-fat diet (15%
of energy) (10). Therefore, it is important to determine the
effects of dietary fructose on meal-associated insulin secre-
tion and the diurnal pattern of leptin production in humans.
This is particularly relevant in light of the fact that per capita
fructose consumption has increased during the past three
decades (11) within the same time frame as a marked increase
in the prevalence of obesity (12, 13).
Abbreviations: AUC, Area under the curve; CNS, central nervous
system; FFA, free fatty acid; GCRC, General Clinical Research Center;
GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-
like peptide-1; HFCS, HFr corn syrup; HFr, high fructose; HGl, high
glucose; TG, triglyceride.
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Other factors, including a number of gastrointestinal hor-
mones that are known to influence food intake and glucose
homeostasis, could potentially contribute to a metabolic pro-
file promoting increased body adiposity after fructose in-
gestion. Ghrelin, a recently discovered enteric hormone, is a
potent orexigen (14, 15) and may play a role in the regulation
of food intake and nutrient selection (16, 17). Circulating
ghrelin concentrations have not been examined in response
to changes of dietary carbohydrate composition in human
subjects, and the influence of fructose on ghrelin secretion is
not known. In contrast, the acute effects of fructose on the
two primary incretin hormones (insulinotropic peptides),
glucose-dependent insulinotropic polypeptide (GIP) and
glucagon-like peptide-1 (GLP-1), have been investigated.
Typically, these hormones are released when glucose is in-
gested, but although acute fructose consumption has also
been reported to stimulate GLP-1 release (18), GIP secretion
is unaffected by fructose (19). However, circulating levels of
these hormones have not been examined over the course of
a day in which glucose and fructose are consumed in the
context of mixed nutrient meals.
Thus, in the present study, we examined circulating glu-
cose, insulin, and leptin concentrations as well as ghrelin,
GLP-1(7-36) (the active form of GLP-1), and GIP over a 24-h
period on 2 separate days during which the subjects con-
sumed three isocaloric (between treatments) mixed nutrient
meals accompanied by either glucose-sweetened [high glu-
cose (HGl)] or fructose-sweetened [high fructose (HFr)] bev-
erages. Furthermore, because the hepatic metabolism of fruc-
tose is considered to favor lipogenesis and triglyceride (TG)
synthesis (20), plasma TG and free fatty acid (FFA) levels
were also measured.
Subjects and Methods
Subjects
Twelve normal-weight women with an age range of 19–33 yr (mean,
25  2 yr) and with a body mass index within the range of 19.8–26.7
kg/m2 (mean, 23.2  0.6) participated in the study. Each subject un-
derwent a telephone interview to assess eligibility. Subjects who re-
ported any food allergies or special dietary restrictions or ingested more
than two carbonated beverages per day were excluded from the study.
Subjects taking any medication were also excluded. Subjects provided
informed consent to participate in the study and were given a physical
examination that included an electrocardiogram and a medical history
to ensure that they had no chronic illnesses. A blood sample was drawn
after an overnight fast. Subjects with fasting blood glucose levels greater
than 5 mmol/liter (90 mg/dl), blood pressure higher than 140/90 mm
Hg, or hemoglobin levels less than 6.8 mmol/liter (11 g/dl) were ex-
cluded from the study. Percentage of body fat was determined in each
subject by bioelectrical impedance (model no. BIA-101A, RJL Systems,
Mt. Clemens, MI) and ranged from 20–40% (mean, 30  2%). Mean
fasting plasma insulin and glucose values were 45  3 pmol/liter and
4.0  0.1 mmol/liter, respectively. Subjects were also administered the
three-factor eating questionnaire (21). This questionnaire evaluates an
individual’s attitude toward food by measuring three factors: dietary
restraint (cognitive control of eating behavior), degree of disinhibition
(disinhibition of control), and susceptibility to hunger. The question-
naire has been validated and can distinguish between dieters and non-
dieters. Subjects scoring no more than 10 on the restraint scale were
classified as nonrestrained eaters, whereas those scoring above 10 were
classified as restrained (21). The magnitude of restraint has been shown
to be highly correlated with body mass index. Seven of the subjects were
classified as unrestrained eaters, and five were classified as restrained
eaters. The experimental protocols were approved by the Committees on
Studies Involving Human Subjects at the University of Pennsylvania
(Philadelphia, PA) and the University of California, Davis (Davis, CA).
Experimental protocol
Each subject was studied under two experimental conditions admin-
istered in random order. The experimental conditions were spaced 1
month apart, and each required a two-night stay in the General Clinical
Research Center (GCRC). The two-night stay comprised a 24-h period
during which dietary intake was controlled (d 1) and a 12-h period
during which subjects consumed food ad libitum (d 2). The two exper-
imental conditions involved dietary manipulations in which subjects
were administered either 1) glucose-sweetened beverages with a con-
trolled diet (HGl condition), or 2) fructose-sweetened beverages with a
controlled diet (HFr condition). All studies were conducted during the
first 7 d of the subjects’ menstrual cycles.
The subjects were instructed to maintain their normal dietary intake
and level of exercise during the interval between study sessions. On the
evenings before the experimental sessions, the subjects entered the
GCRC at the Hospital of the University of Pennsylvania at 1700 h.
Subjects were given dinner at 1800 h, after which they remained fasted
until the next morning. The subjects were permitted to select the type
of food, with the quantity based on their caloric requirements and an
energy factor of 1.3. The food offered was that typically provided by the
GCRC metabolic kitchen and consisted of a variety of meal selections.
Macronutrient composition of the dinner reflected the same ratios of
protein, fat, and carbohydrate as the test diets. At 0730 h the next
morning, an iv catheter was inserted and kept patent with a slow saline
infusion. Blood sampling commenced at 0800 h (d 1) and continued until
0800 h the next morning (d 2). Blood samples for substrate and hormone
measurements were collected while the subjects consumed three stan-
dardized meals. Each meal was accompanied by either HFr or HGl
sweetened beverages. Subjects were required to ingest the meals within
a 15-min time period. Hunger was rated throughout the day using visual
analog scales.
On completion of the blood sampling period on the morning of the
second day, subjects remained in the GCRC until 1900 h (d 2). Before
each meal (breakfast, lunch, dinner), subjects were given a prepared
menu and asked to select the foods they wished to eat. The selected foods
were then offered in excess, and subjects were instructed to eat as little
or as much as they wished. Subjects were not aware that their food intake
was being monitored.
Diets
The meals consisted of whole foods and were designed by a registered
dietitian. The nutrient composition of the diets was determined using the
Nutrition Data System, University of Minnesota (Minneapolis, MN).
Each subject ingested three meals per day. Breakfast consisted of a bagel,
cream cheese, and scrambled eggs. Lunch consisted of a chef’s salad with
turkey, cheese, and a dinner roll. Dinner consisted of a chicken breast,
mashed potatoes, carrots, and a roll with butter. The energy content of
the meals was based on an estimate of that subject’s daily energy re-
quirement. Energy requirements were estimated by the Mifflin equation
with an activity factor of 1.3 (22). The activity factor was low because the
subjects remained relatively sedentary during the study sessions. The
meals contained 30% energy from fat, 15% from protein, and 55% from
carbohydrate. Of the 55% of total energy intake provided by carbohy-
drate, 25% was derived from complex carbohydrate, and 30% consisted
of either free glucose or free fructose in the form of a beverage. The
monosaccharides were prepared as 15% solutions, flavored with a pop-
ular unsweetened drink mix. Subjects were blinded in regard to the
sweetener in the beverages. Mean energy intake was 1804  129 kcal
(range, 1282–2002). Breakfast was given at 0900 h, lunch at 1300 h, and
dinner at 1800 h. Subjects were required to ingest all of the food provided
within 15 min and were observed for compliance. Each subject ingested
a minimum of 1 liter of water over the course of each study day. Both
the HFr and HGl beverages were well tolerated by all subjects.
Hunger ratings and food intake measurements
Subjects were given a Palm Pilot programmed with a series of ques-
tions addressing hunger and satiety. The questions were: 1) How hungry
2964 J Clin Endocrinol Metab, June 2004, 89(6):2963–2972 Teff et al. • Fructose Effects on Leptin, Ghrelin, and TGs
do you feel right now? 2) How full is your stomach right now? 3) How
strong is your desire to eat? 4) How much food could you eat right now?
and 5) How nauseated do you feel right now? The answers to the
questions were rated on a visual analog scale and were anchored with
the words “none” to “extremely” or, in the case of question 4, “an
extremely large amount.” An alarm on the Palm Pilot was set at pre-
programmed time points relative to meal ingestion. There were 24 time
points during d 1 of the study and 18 time points during d 2. Time points
were generally every 30 min during the day and were more frequent
around the times of the meals.
On completion of the blood sampling period (0730 h), subjects were
given a breakfast menu offering eggs, bagels, turkey bacon, and butter.
Subjects selected which items they wanted, and these foods were then
offered in portions three times the size of a normal serving. Unknown
to the subjects, foods were weighed beforehand, and the remaining
foods were weighed after the food tray was taken away from the subject.
The difference in the weight of each food was recorded as the amount
of food ingested. The macronutrient content of the food ingested was
determined using Nutritionist 3 (Esha Research, Salem, OR). Where
applicable, the manufacturer’s reported macronutrient content of the
prepared foods was used. For lunch and dinner, the food choices were
chicken, mashed potatoes, rice, macaroni and cheese, green beans,
grapes, apple slices, orange sections, Jell-O, and vanilla pudding. In
addition, decaffeinated coffee, decaffeinated tea, fruit juice, milk (2%,
nonfat, whole), and water were offered as beverages. The foods selected
were specifically chosen to be simple and of minimal hedonic value (i.e.
pleasant, but not especially palatable) to minimize subjects selecting
food for taste as opposed to hunger.
Blood sampling
Blood samples were taken at 30-min intervals around periods of meal
ingestion and during the predicted nocturnal rise of leptin secretion (i.e.
5 h after the evening meal) and at hourly intervals at other times. After
the three baseline samples, which were collected at 0800, 0830, and
0900 h before ingestion of the first meal, a total of 33 additional samples
were collected 30–60 min apart. Each sample collection involved the
removal of 1 ml of blood to clear the catheter tubing, followed by a 5-ml
collection into Vacutainer tubes (Becton, Dickinson and Co., Franklin
Lakes, NJ) containing EDTA. Dipeptidyl peptidase IV (Linco Research,
Inc., St. Charles, MO) and protease inhibitor cocktails containing Tra-
sylol and leupeptin were added to inhibit proteolysis, and the samples
were kept on ice for not longer than 1 h. Samples were then centrifuged,
aliquoted, and stored at 70 C until assayed.
Assays and data analysis
Plasma glucose and lactate were measured with a YSI 2300 StatPlus
Glucose Analyzer (Yellow Springs Instruments, Yellow Springs, OH).
Plasma insulin was measured in duplicate by RIA using 125I human
insulin (Amersham, Piscataway, NJ) and human insulin standards from
Linco Research, Inc. as previously described (23). Plasma leptin was
measured with a RIA for human leptin with reagents from Linco Re-
search, Inc. Plasma TGs were measured with reagents from Sigma (St.
Louis, MO), and FFAs were measured with reagents from Wako (Rich-
mond, VA) using an automated clinical autoanalyzer. Total plasma
ghrelin was measured without an extraction step using a commercial
RIA (Phoenix Peptide, Phoenix, AZ) as described previously (24, 25).
Biologically active GLP-1(7-36) was measured in unextracted plasma with
a two-site noncompetitive immunoassay based on enzyme-labeled
quantification of GLP-1 detected with a fluorogenic substrate (Linco
Research, Inc.). GIP was measured using a RIA as described by Kuzio
et al. (26) and modified by Morgan et al. (27). Rabbit anti-GIP was
generously supplied by Dr. L. M. Morgan (University of Surrey, Surrey,
UK). Inter- and intraassay variations for GIP were 10 2% and 5 1%,
respectively.
The area under the curve (AUC) was calculated for glucose, insulin,
GLP-1, GIP, and TGs with a data spreadsheet program (Microsoft Excel;
Microsoft, Redmond, WA) using the trapezoidal method. AUCs for
ghrelin and FFA are not presented because ghrelin and FFA levels
decreased rather than increased in response to meal ingestion. The mean
of the three baseline values was determined, and net AUC was calcu-
lated by subtracting the areas below baseline from AUC values above
baseline. AUCs for glucose, insulin, GIP, GLP-1, and TGs are expressed
as units per 23 h above each subject’s fasting baseline levels because the
first hour of sampling determined the baseline levels. The nadirs and
peaks for plasma leptin were determined as the two lowest consecutive
morning values before 1200 h and the two highest consecutive nighttime
values after 2000 h, respectively, as previously described (1). The AUCs
for leptin are therefore expressed as units above each subject’s nadir over
12 or 24 h. Differences between overall responses to the two diets were
determined with paired t tests.
Hunger ratings were analyzed using both AUCs and repeated mea-
sures ANOVA. Results from d 1 and 2 were analyzed independently.
Differences in food intake and macronutrient selection were determined
on d 2 only by multivariate ANOVA. In addition, hunger and food intake
data were analyzed and compared by group, restrained vs. nonre-
strained. Results are presented as mean  se (sem). Significance for all
measures was defined as P  0.05.
Results
Plasma glucose and insulin
Baseline fasting glucose concentrations were similar on the
2 experimental days (4.7 0.1 mmol/liter, HGl, vs. 4.6 0.1
mmol/liter, HFr). As expected, plasma glucose excursions
were lower after HFr meals than after HGl meals (Fig. 1). This
effect was most pronounced after dinner. The AUC for glu-
cose over the first 12 h and the entire 24-h sampling period
was reduced by 55 7% and 39 9%, respectively (both P
0.001), on the day HFr beverages were consumed compared
with the day HGl beverages were consumed (Table 1).
Mean fasting insulin concentrations were slightly lower on
the HFr treatment day (48.0 4.8 pmol/liter, HGl, vs. 38.4
3.0 pmol/liter, HFr). Plasma insulin responses to each HFr
meal were markedly lower, and average peak insulin re-
sponses were reduced by 65 5% (P 0.001) compared with
after HGl meals; however, the timing of the peaks was not
significantly different (Fig. 2). Overall insulin secretion dur-
ing the 23-h study as defined by the AUC above fasting
concentrations was blunted by 49  5% (P  0.001) during
HFr consumption compared with the day of HGl consump-
tion (Table 1).
FIG. 1. Plasma glucose concentrations during a 24-h period (0800–
0800 h) in 12 women consuming HGl or HFr beverages with each
meal. To convert glucose concentrations to millimoles per liter, mul-
tiply by 0.556.
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Plasma leptin
Plasma leptin concentrations at 0800 h and morning nadir
leptin concentrations, which generally occurred between
1000 and 1200 h, were not different between the HFr and HGl
study days (13.0  2.0 ng/ml, HGl, vs. 11.7  0.8 ng/ml,
HFr). On the day the HGl meals were consumed, plasma
leptin increased from a morning nadir of 11.2  1.4 ng/ml
to a nocturnal (0030–0230 h) peak of 24.8  2.2 ng/ml ( 
13.6 1.4 ng/ml; P 0.001; Fig. 3). The percentage change
over nadir concentrations was 136.2 17.3% (P 0.001). On
the HFr day, plasma leptin increased from a morning nadir
of 9.5  0.7 ng/ml to a nocturnal peak of 19.8  1.7 ng/ml
(  10.3  1.1 ng/ml; P  0.001; Fig. 3). The percentage
change over nadir levels for the HFr day was108.8 9.3%
(P 0.001). The amplitude of the nocturnal peak on the HFr
day was reduced by 24 6% (P 0.003) compared with the
HGl day. The AUC for leptin during the first 12 h of the study
was 33  7% smaller (P  0.001), and overall leptin produc-
tion as assessed by the 24-h AUC was 24  7% (P  0.005)
smaller on the HFr day than on the HGl day (Table 1).
Ghrelin
Baseline fasting plasma ghrelin concentrations were not
different on the HGl days (316  35 pg/ml) compared with
the HFr days (300  28 pg/ml). There was a diurnal pattern
in the ghrelin levels (Fig. 4), with a nocturnal peak between
2300 and 0300 h that gradually declined until 0800 h, similar
to what has been described previously (15, 25). On the HGl
day, plasma ghrelin decreased by approximately 30–35%
after each meal. The decrease from fasting baseline levels was
105  21, 92  21, and 97  21 pg/ml (all P  0.0025)
(Fig. 4) after breakfast, lunch, and dinner, respectively. When
fructose was consumed, there was higher interindividual
variability, and the mean postprandial suppression of ghre-
lin below baseline levels was markedly attenuated, decreas-
ing by52 30 (not significant),34 20 (not significant),
and 53  18 pg/ml (P  0.01), after breakfast, lunch, and
dinner, respectively (Fig. 4). The degree of suppression of
ghrelin was significantly greater after each glucose-contain-
ing meal compared with the corresponding fructose-
containing meal (P  0.05 for each meal). During the
evening/early morning hours from 2300–0300 h of the HFr
day, plasma ghrelin concentrations were elevated compared
with baseline levels (  72  31 pg/ml; P  0.025). In
contrast, plasma ghrelin concentrations were not increased
above baseline levels during this time on the HGl day ( 
7  34 pg/ml). However, due to a large degree of indi-
vidual variation, the nighttime increase of ghrelin levels was
TABLE 1. AUC above baseline (0800–0900 h) for the 23 h after the three morning baseline samples were collected, except for leptin,
which is the 24-h AUC above morning trough concentrations
HGl HFr t P
Glucose (mmol/liter23 h) 43.4  5.2 23.9  3.7 4.3 0.0025
Lactate (mmol/liter23 h) 7.6  2.0 18.5  2.7 3.6 0.0025
Insulin (pmol/liter23 h) 6658.2  495.6 3261.6  309.0 7.0 0.0001
Leptin day (ng/ml12 h) 108.5  9.8 69.1  7.5 3.9 0.0025
Leptin night (ng/ml12 h) 191.3  28.5 149.4  7.6 2.0 0.05
Leptin total (ng/ml24 h) 300.8  30.7 218.5  22.8 2.8 0.01
GIP (pg/ml23 h) 49.2  16.8 51.5  11.5 0.9 ns
GLP-1(7-36) (pg/ml23 h) 46.0  19.7 112.7  32.8 3.4 0.01
TG (g/liter23 h) 2.1  1.6 13.8  6.4 3.0 0.01
ns, Not significant.
FIG. 2. Plasma insulin concentrations during a 24-h period (0800–
0800 h) in 12 women consuming HGl or HFr beverages with each
meal. To convert insulin concentrations to micromoles per liter, mul-
tiply by 6.
FIG. 3. Change of plasma leptin concentrations over mean baseline
levels (0800–0900 h) during a 24-h period (0800–0800 h) in 12 women
consuming HGl or HFr beverages with each meal. To convert leptin
concentrations to nanomoles per liter, multiply by 0.0625
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not significantly greater on the HFr day compared with the
HGl day (P  0.075).
GIP and GLP-1
Plasma levels of GIP (654  126 pg/ml, HGl, vs. 583  83
pg/ml, HFr) and GLP-1 (3.6  0.7 pg/ml, HGl, vs. 3.5  0.5
pg/ml, HFr) were similar in the fasting state before admin-
istration of each dietary condition and increased after each
meal on both the HFr day and the HGl day (Figs. 5 and 6).
After meal ingestion, GIP concentrations increased more rap-
idly when glucose was consumed compared with after fruc-
tose ingestion. Overall, GIP levels remained higher through-
out the daytime hours on the HGl day than on the HFr day.
When HGl beverages were consumed with breakfast, plasma
GIP levels increased within 30 min by 726 120 pg/ml (P
0.001) (%  158  52%; P  0.01), whereas when HFr
beverages were consumed plasma GIP levels were not sig-
nificantly increased until 60 min after breakfast. A similar 30-
to 60-min delay of plasma GIP responses was also observed
after lunch and dinner on the HFr day (Fig. 5). The plasma
GIP response after breakfast was larger when glucose was
ingested compared with fructose. The AUC for GIP after
breakfast was 6722 1502 pg/mlh on the HGl day and was
lower on the HFr day, averaging 3825 742 pg/mlh (% vs.
HGl  31  9%; P  0.005). No significant differences in
the magnitude of the GIP response were observed after lunch
or dinner or in the overall 23-h GIP response (AUC above
baseline) between the two treatments (Table 1).
Peak values of the active form of GLP-1, GLP-1(7-36), after
meals did not differ between HFr and HGl days; however,
GLP-1(7-36) levels remained elevated for a longer period (up
to 120 min) after HFr than after HGl meals (Fig. 6). Although
plasma GLP-1(7-36) tended to remain elevated after breakfast
on HFr day, integrated GLP-1(7-36) responses after breakfast
were not significantly different on the HFr and HGl days.
However, the integrated GLP-1(7-36) responses were signifi-
cantly larger on the HFr day after lunch (AUC  20.1  4.0
vs. 10.2 3.3 pg/mlh; P 0.003 vs. HGl) and dinner (AUC
11.4 2.7 vs. 6.6 3.2 pg/mlh; P 0.05 vs. HGl), due to the
prolongation of the responses. As a result, the integrated 24-h
plasma GLP-1(7-36) concentrations above baseline were sig-
nificantly greater on the HFr day compared with the HGl day
(Table 1).
Plasma TGs and FFAs
Baseline plasma TGs were not different on the experimen-
tal days (0.76 0.06 g/liter, HGl, vs. 0.73 0.08 g/liter, HFr).
Plasma TG increased more rapidly during the intermeal in-
terval (4–5 h after breakfast) and achieved higher peak con-
centrations when the subjects consumed HFr beverages than
when they consumed the HGl beverages with meals (Fig. 7).
Plasma TG remained elevated after meals and throughout
FIG. 4. Change of plasma ghrelin concentrations over mean baseline
levels (0800–0900 h) during a 24-h period (0800–0800 h) in 12 women
consuming HGl or HFr beverages with each meal. To convert ghrelin
concentrations to picomoles per liter, multiply by 0.296.
FIG. 5. Plasma GIP concentrations during a 24-h period (0800–0800
h) in 12 women consuming HGl or HFr beverages with each meal. To
convert GIP concentrations to picomoles per liter, multiply by 0.201.
FIG. 6. Plasma active form of GLP-1 [GLP-1(7-36)] concentrations dur-
ing a 24-h period (0800–0800 h) in 12 women consuming HGl or HFr
beverages with each meal. To convert GLP-1(7-36) concentrations to
picomoles per liter, multiply by 0.298.
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most of the 24-h study period on the HFr day, whereas on the
HGl day plasma TGs declined after the major postprandial
peaks and remained below baseline levels during the night-
time hours (Fig. 7). Plasma TG levels at 0800 h on the morning
after the HFr day were 0.24  0.05 g/liter (24  5 mg/dl)
higher (P  0.001) than baseline, representing a 34.9  9.1%
(P 0.003) increase over baseline concentrations. In addition,
the plasma TG concentration at 0800 h was significantly
greater than at this same time after the HGl day (P  0.003).
Overall, the 23-h AUC for TG relative to baseline concen-
trations was slightly negative on the HGl day, but markedly
increased above baseline levels on the HFr day (Table 1).
Fasting plasma FFA levels were similar on the 2 study days
and were rapidly and markedly suppressed after both HGl
(0.51 0.12 g/liter) and HFr (0.49 0.05 g/liter) meals. The
increase of plasma FFA levels after postmeal suppression
was larger after lunch, and the nocturnal levels after the
postdinner nadir appeared higher on the HGl than the HFr
day (Fig. 8). However, the overall FFA exposure above fast-
ing baseline levels was not statistically different between the
2 study days, and the small differences would not be ex-
pected to influence insulin sensitivity. It should be noted that
the temporal pattern of the changes of plasma FFA and
plasma ghrelin concentrations were quite similar, with in-
creases of ghrelin preceding the increases of FFAs by ap-
proximately 15 min.
Hunger ratings and food intake measurements
Integrated hunger ratings in all subjects were not signif-
icantly different between the HGl and HFr meals on d 1 when
the diet was controlled (22,620  2,142/15 h, HGl, vs.
22,554  3,283/15 h, HFr) or on d 2 when subjects were
permitted to eat ad libitum (11,622  1,463/10 h, HGl, vs.
11,244  1,712/10 h, HFr). Furthermore, total energy intake
(1816  509 kcal, HGl, vs. 1958  598 kcal, HFr), total fat
intake (37.1  13.9 g, HGl, vs. 42.2  13.5 g, HFr), and total
carbohydrate intake (275.7  111 g, HGl, vs. 289.5  101 g,
HFr) were not significantly different between the 2 treatment
days.
When subjects were grouped into restrained and unre-
strained eaters, restrained eaters exhibited significant in-
creases of hunger on d 1 of the HFr treatment (22,680 
4,925/15 h) compared with d 1 of the HGl treatment
(18,400  2,423/15 h; F(1,8)  8.0; P  0.02; Fig. 9). Unre-
strained eaters did not exhibit any differences in hunger
ratings on d 1. No significant differences in hunger were
recorded on d 2 in the restrained eaters. The lack of increase
in hunger on the day after the HFr treatment in the restrained
eaters would be explained by the significant (50%) increase
in the amount of dietary fat (known to be satiating in the
short-term) ingested on the second day of the study in this
group of subjects (HGl, 32 6 g, 289 55 kcal; vs. HFr, 47
6 g, 425  53 kcal; F(1,10)  6.62; P  0.03) (Fig. 9). Thus,
restrained eaters recorded increased hunger during the day
of HFr ingestion when their dietary intake was controlled.
On the subsequent day, in an ad libitum feeding situation,
they exhibited a compensatory increase in fat intake, thereby
alleviating the increase in hunger. The increase in fat intake
was not reflected by an increase in total energy intake in this
small subset of individuals, although mean values tended to
be higher (20%) in the restrained subjects on the HFr day
(1801  238 kcal, HGl, vs. 2154  268 kcal, HFr). As would
be expected, unrestrained eaters consumed more fat than
restrained eaters in an ad libitum setting on the HGl treatment
day. However, in contrast to the significant increase of fat
intake after HFr exposure observed in restrained eaters, the
unrestrained eaters did not exhibit either an increase in hun-
ger or an increase in food intake after the HFr treatment.
These differential responses between subjects with the two
behavioral subtypes do not appear to result from differences
in their hormonal responses because no significant differ-
ences were found in plasma ghrelin or leptin responses to the
two treatments between the restrained and unrestrained eat-
ers. Thus, it may be that restrained eaters were more sensitive
to the ensuing behavioral effects of the endocrine/metabolic
FIG. 7. Plasma TG concentrations during a 24-h period (0800–0800
h) in 12 women consuming HGl or HFr beverages with each meal. To
convert TG concentrations to millimoles per liter, multiply by 0.0114.
FIG. 8. Plasma FFA concentrations during a 24-h period (0800–0800
h) in 12 women consuming HGl or HFr beverages with each meal. To
convert FFA concentrations to millimoles per liter, multiply by 3.55.
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profile elicited by fructose consumption on the preceding
day.
Discussion
The major aim of this study was to compare effects of
fructose and glucose on endocrine signals involved in the
regulation of body adiposity and energy metabolism, as well
as glucose and lipid metabolism. In a previous study in
normal-weight women, we reported that high-fat, low-
carbohydrate meals produced smaller excursions of plasma
insulin and glucose than low-fat, high-carbohydrate meals,
resulting in reduced circulating leptin concentrations over a
24-h period (1). The results of the present study, also in
young, normal-weight women, indicate that like fat, con-
suming fructose with a mixed meal results in substantially
smaller postprandial plasma glucose and insulin excursions
and attenuated circulating leptin profiles when compared
with glucose.
Fructose does not stimulate insulin secretion (7), presum-
ably because pancreatic-cells have low levels of the fructose
transporter, glucose transporter 5 (28). Thus, iv fructose in-
fusion only marginally increases circulating insulin concen-
trations (8), and ingested fructose is ineffective in eliciting
postprandial insulin secretion (29). When the effects of iv
glucose and fructose infusion were compared in monkeys,
plasma leptin concentrations were increased by 4 h after the
start of the glucose infusion. In contrast, leptin did not in-
crease during infusion of the same amount of fructose (8). We
have reported that leptin production by adipocytes is reg-
ulated by insulin-mediated glucose metabolism (2, 30). Ac-
cordingly, the reduction of circulating leptin in response to
fructose infusion is likely the result of the smaller insulin and
glucose excursions leading to less insulin-induced glucose
utilization by adipose tissue. Thus, in the present study, as
predicted, consumption of three high fructose meals resulted
in reductions in the amplitude of the diurnal leptin pattern
(peak nadir) and of circulating leptin levels over 24 h when
compared with HGl meals. The diurnal pattern of the cir-
culating leptin may be an important determinant of its bio-
logical effects because the proportional amplitude (percent-
age change) of leptin was predictive of the loss of weight and
body fat during a 12-wk ad libitum low-fat diet (10).
The smaller postprandial excursions of circulating glucose
and insulin after consumption of fructose beverages with
meals may also contribute to the attenuated suppression of
ghrelin secretion after subjects consumed HFr beverages,
compared with HGl beverages with meals. Insulin and glu-
cose have been shown to decrease circulating ghrelin in ro-
dents and humans (31–34). Ghrelin has been the focus of
considerable attention due to its potent effects to stimulate
food intake in animals (35) and humans (14). The suppression
of ghrelin after meal ingestion is blunted in obese subjects
compared with normal-weight subjects (36), and circulating
ghrelin is markedly elevated in patients with Prader-Willi
syndrome (24, 37), a genetic disorder characterized by
marked hyperphagia and obesity. Plasma ghrelin levels in-
crease after diet-induced weight loss (25) but remain dra-
matically reduced in patients after weight loss induced by
gastric bypass surgery (25, 38). The relative elevation of
plasma ghrelin after fructose ingestion in the present study
suggests that a failure of fructose to suppress ghrelin, along
with reduced insulin and leptin, could contribute to de-
creased satiety and increased food intake during long-term
fructose consumption.
In this study, we observed delayed and reduced GIP re-
sponses and prolonged GLP-1 responses when HFr bever-
ages were consumed with each meal. Other investigators
have reported that ingestion of fructose by itself does not
stimulate GIP release (19). It is unlikely that the decreased
GIP responses are due to delayed gastric emptying because
fructose ingestion increases gastric emptying (39). We hy-
pothesize that although consumption of the HGl beverages
with a meal provides a rapid direct stimulus for GIP release,
GIP release after the consumption of the HFr beverages with
a mixed meal is dependent on delivery of the other nutrients
in the meal to the intestine, resulting in an attenuated/de-
layed GIP response.
Although the effects of glucose and fructose in isolation on
FIG. 9. Left, Hunger ratings (AUC over a 15-h period) on d 1 during the HGl and HFr dietary manipulations. Significant treatment by time
by behavioral trait (restraint) interactions were found on d 1 when food consumption was controlled. Restrained (n  5), but not unrestrained
(n 7), subjects reported greater hunger on the HFr day compared with the HGl day [(F(1,8) 8.0; P 0.03)]. Right, Total fat intake (kilocalories)
on the day after dietary HGl diets and HFr diets during which subjects were permitted ad libitum and eating. Unrestrained subjects selected
significantly more total fat than restrained subjects on the day after HGl (P  0.05). No significant differences in total fat intake between the
HGl and HFr days were observed in unrestrained eaters. Significantly greater fat intake was observed on the day after HFr compared with
after HGl in the restrained eaters [F(1,10)  6.62; P  0.03].
Teff et al. • Fructose Effects on Leptin, Ghrelin, and TGs J Clin Endocrinol Metab, June 2004, 89(6):2963–2972 2969
GLP-1 release have been reported (18, 19), the effects of
consuming the two sugars in combination with mixed meals
over a 24-h period have not been compared. The results
indicate that fructose ingestion prolonged the postprandial
release of GLP-1. Given that we specifically measured the
intact peptide, which is rapidly metabolized by dipeptidyl
peptidase IV (40), it is likely that the prolonged GLP-1(7-36)
responses are due to increased secretion rather than reduced
clearance. It does not appear likely that either the observed
delay in GIP release or increased GLP-1 release makes a
major contribution as incretins (41) to the differences in in-
sulin secretion after glucose and fructose consumption be-
cause the temporal patterns of the hormones do not coincide
with the insulin responses. Although GLP-1 responses to
meals could potentially lead to decreased food intake, per-
haps by delaying gastric emptying (42), the magnitude of
difference is relatively small.
Ingestion of HFr beverages with meals resulted in elevated
TG levels compared with HGl beverages. The increase in
postprandial TG levels after fructose ingestion is likely to
reflect differences in the hepatic metabolism of fructose and
glucose. Fructose is phosphorylated by fructokinase to fruc-
tose-1-phosphate. Unlike the glycolytic metabolism of glu-
cose via phosphofructokinase, fructokinase is not subject to
feedback inhibition by cytosolic citrate and ATP (20). Thus,
in contrast to glucose, when large amounts of fructose are
ingested, the glycolytic pathway becomes saturated with the
fructose carbon, and TG production is facilitated from in-
creased carbon flux into both the glycerol and the acyl por-
tions of TG (20, 43). Decreased TG clearance could also con-
tribute to the increased TGs after fructose ingestion (44, 45).
The observed decrease in circulating leptin levels could be an
additional mechanism by which fructose influences TG lev-
els because leptin is known to promote fat use (3). Other
investigators have reported that TG increases during more
long-term consumption of diets high in fructose (46) or su-
crose (47) compared with HGl or starch diets (48). We have
reported that the effect of fructose to increase postprandial
TG persists during 10 wk of fructose consumption and that
plasma levels of the atherogenic lipoprotein, Apo-B, are also
elevated after long-term fructose, but not glucose consump-
tion (49). Thus, it is possible that the type of carbohydrate,
specifically the fructose contained in added sugars, contrib-
utes to the known effect of high-carbohydrate diets to raise
TG levels. Furthermore, existing hyperlipidemia (45) and/or
insulin resistance (50) may predispose individuals to greater
postprandial hypertriglyceridemia after consuming fructose.
The two main sources of fructose in the U.S. diet are
sucrose, which consists of 50% fructose, and HFr-fructose
corn syrup (HFCS), typically containing 55% fructose. It is
estimated that fructose consumption has increased by at least
26% over the past three decades (11), primarily due to the
increased use of HFCS in soft drinks and other beverages.
The average per capita disappearance data for added fruc-
tose in 1997 from the combined use of sucrose and HFCS was
81 g/d (11). Individuals in the 90th percentile of fructose
intake are estimated to consume between 1.5 and 2.5 times
the mean intake (51). In the present study, the amount of
fructose consumed was 45 g at each meal, which is approx-
imately the same amount of fructose as that found in 670 ml
(24 oz) of soft drink. Because this is equivalent to approxi-
mately 1.5 times the average intake, it is likely that a signif-
icant portion of the population is consuming comparable
amounts of fructose.
The prevalence of obesity in the U.S. population (12, 13)
has increased over the same time period as the increase in
fructose consumption. Results of the present study indicate
that fructose appears to behave more like fat than like other
carbohydrates with respect to insulin secretion, leptin pro-
duction, and postprandial TG levels. Furthermore, fructose,
unlike glucose does not cross the blood-brain barrier and
could potentially contribute to increased energy intake be-
cause it does not trigger CNS glucose sensors involved in the
regulation of food intake (52). Increased fructose consump-
tion, along with consumption of larger portions of high-fat
foods and inactivity, may be a contributing factor to the
increased incidence of obesity. Studies in humans have re-
ported weight gain during prolonged ad libitum consumption
of fructose (53, 54), In addition, fructose ingestion leads to
increased rates of de novo lipogenesis (55) compared with
eucaloric glucose ingestion (56). Children who consume
more than 265 ml (9 oz) of soda per day have a 15% higher
energy intake than those who do not regularly consume soft
drinks (57), and for each sugar-sweetened beverage con-
sumed, both body mass index and the frequency of obesity
in children are increased (58).
We found that ingestion of meals with HFr beverages
resulted in subsequent increases of hunger and fat intake
compared with the same meals with HGl beverages, but only
in a subset of subjects with a psychological profile of dietary
restraint. These data suggest that certain individuals are
more susceptible to the effects of the endocrine/metabolic
profile elicited by fructose ingestion. Many obese individuals
exhibit a high degree of dietary restraint. Thus, these indi-
viduals remain obese despite their efforts to curtail caloric
and fat intake through dieting (59, 60). Furthermore, children
even as young as 5 yr can exhibit restrained eating behavior
(61, 62). These results demonstrate one of the difficulties in
identifying the physiological mechanisms regulating body
weight in humans, i.e. that psychological attitudes toward
food impact eating behavior (63–65). Although the limited
number of subjects in the present study precludes any de-
finitive conclusions, the results provide groundwork for fu-
ture investigations. The finding that ingestion of fructose
beverages with mixed nutrient meals is associated with a
subsequent increase of food intake contrasts with two other
studies that reported decreased caloric intake after a fructose
preload compared with a glucose preload. However, in those
experiments, the effects of the fructose on food intake were
only evident when the sugar was ingested alone and not in
combination with a mixed meal (66, 67). Furthermore, unlike
the present study, which examined the effects of repeated
fructose ingestion over 24 h, previous studies only measured
acute responses.
In summary, consuming HFr beverages with meals results
in lower circulating insulin and leptin concentrations and
higher ghrelin and TG levels compared with consumption of
HGl beverages. Because insulin, leptin, and possibly ghrelin
function as key signals to the CNS in the long-term regulation
of energy balance (4, 35, 52, 68), prolonged consumption of
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diets high in energy from fructose could lead to increased
caloric intake and contribute to weight gain and obesity. The
sustained elevation of plasma TG levels after fructose in-
gestion suggests that chronic fructose consumption could
contribute to atherogenesis and cardiovascular disease.
Additional studies are needed to investigate the effects of
prolonged fructose consumption on the endocrine signals
regulating energy homeostasis, insulin action, and lipid me-
tabolism, as well as its long-term effects on appetite and
energy intake.
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